Abbott Laboratories (ABT) Holder Sivik Global Healthcare Lowered Its Stake by $1.71 Million; Tnb Financial Trimmed Its Duke Energy New Com New (DUK) Stake by $741,300

April 21, 2018 - By Winifred Garcia

Duke Energy Corporation (NYSE:DUK) Logo

Tnb Financial decreased its stake in Duke Energy Corp New Com New (DUK) by 6.22% based on its latest 2017Q4 regulatory filing with the SEC. Tnb Financial sold 8,825 shares as the company’s stock declined 8.40% with the market. The institutional investor held 133,060 shares of the power generation company at the end of 2017Q4, valued at $11.19M, down from 141,885 at the end of the previous reported quarter. Tnb Financial who had been investing in Duke Energy Corp New Com New for a number of months, seems to be less bullish one the $56.08B market cap company. The stock decreased 1.07% or $0.84 during the last trading session, reaching $77.68. About 2.76 million shares traded. Duke Energy Corporation (NYSE:DUK) has declined 6.87% since April 21, 2017 and is downtrending. It has underperformed by 18.42% the S&P500.

Krishen Sud decreased its stake in Abbott Laboratories (ABT) by 21.43% based on its latest 2017Q4 regulatory filing with the SEC. Sivik Global Healthcare Llc sold 30,000 shares as the company’s stock rose 5.88% while stock markets declined. The hedge fund run by Krishen Sud held 110,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $6.28M, down from 140,000 at the end of the previous reported quarter. Sivik Global Healthcare Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $103.37B market cap company. The stock decreased 1.15% or $0.69 during the last trading session, reaching $59.19. About 5.87M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 21, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Since October 23, 2017, it had 1 buy, and 18 insider sales for $23.52 million activity. Ford Robert B also sold $2.69 million worth of Abbott Laboratories (NYSE:ABT) shares. The insider Bracken Sharon J sold $126,559. On Wednesday, February 28 the insider Contreras Jaime sold $375,381. $5.43M worth of Abbott Laboratories (NYSE:ABT) shares were sold by Salvadori Daniel Gesua Sive. $27,213 worth of Abbott Laboratories (NYSE:ABT) shares were sold by PEDERSON MICHAEL J. 11,106 shares valued at $667,804 were sold by Fussell Stephen R on Wednesday, February 28.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 106 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, April 18 by Jefferies. The firm earned “Neutral” rating on Thursday, April 28 by Piper Jaffray. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, October 19. BMO Capital Markets has “Market Perform” rating and $5 target. The stock has “Buy” rating by BTIG Research on Wednesday, June 21. As per Thursday, July 20, the company rating was maintained by BMO Capital Markets. The firm has “Hold” rating by BMO Capital Markets given on Monday, October 2. The stock of Abbott Laboratories (NYSE:ABT) earned “Neutral” rating by Citigroup on Thursday, October 19. William Blair downgraded the shares of ABT in report on Friday, January 29 to “Market Perform” rating. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Wednesday, January 24 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Tuesday, June 14.

Sivik Global Healthcare Llc, which manages about $250.21M and $269.45M US Long portfolio, upped its stake in Amerisourcebergen Corp Com Stk (NYSE:ABC) by 20,000 shares to 60,000 shares, valued at $5.51 million in 2017Q4, according to the filing. It also increased its holding in Express Scripts Holding Company Com (NASDAQ:ESRX) by 5,000 shares in the quarter, for a total of 35,000 shares, and has risen its stake in Dr Reddy’s Laboratories Ltd Adr (NYSE:RDY).

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It improved, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Comerica Secs invested 0.48% of its portfolio in Abbott Laboratories (NYSE:ABT). Vnbtrust Natl Association holds 0.13% or 4,002 shares. New England & Mngmt owns 22,827 shares or 0.93% of their US portfolio. Cap One National Association holds 26,855 shares. Vaughan David Investments Inc Il invested in 1.3% or 489,548 shares. Tnb Financial reported 26,372 shares stake. Toth Advisory holds 146,200 shares. Johnson Financial Gru reported 13,262 shares or 0.09% of all its holdings. Argyle Cap stated it has 0.34% in Abbott Laboratories (NYSE:ABT). The Ohio-based Cleararc has invested 0.34% in Abbott Laboratories (NYSE:ABT). Hollow Brook Wealth Mngmt Ltd Liability has 45,155 shares. Amg Fincl Bank invested in 60,567 shares or 0.22% of the stock. Jacobs And Ca accumulated 102,132 shares. 11,627 were reported by Allen Inv. Cibc Bancorp Usa has 28,328 shares.

Analysts await Duke Energy Corporation (NYSE:DUK) to report earnings on May, 10 before the open. They expect $1.12 EPS, up 7.69% or $0.08 from last year’s $1.04 per share. DUK’s profit will be $808.51 million for 17.34 P/E if the $1.12 EPS becomes a reality. After $0.94 actual EPS reported by Duke Energy Corporation for the previous quarter, Wall Street now forecasts 19.15% EPS growth.

Among 20 analysts covering Duke Energy (NYSE:DUK), 5 have Buy rating, 4 Sell and 11 Hold. Therefore 25% are positive. Duke Energy had 88 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, March 26 by SunTrust. Morgan Stanley maintained Duke Energy Corporation (NYSE:DUK) rating on Thursday, March 8. Morgan Stanley has “Equal-Weight” rating and $83 target. The company was downgraded on Wednesday, January 11 by Citigroup. SunTrust maintained it with “Hold” rating and $89.0 target in Monday, October 23 report. SunTrust maintained Duke Energy Corporation (NYSE:DUK) on Monday, December 11 with “Hold” rating. Bank of America maintained it with “Neutral” rating and $81 target in Wednesday, April 18 report. Suntrust Robinson maintained Duke Energy Corporation (NYSE:DUK) on Monday, October 19 with “Neutral” rating. Goldman Sachs downgraded Duke Energy Corporation (NYSE:DUK) on Wednesday, January 10 to “Hold” rating. The firm has “Buy” rating given on Friday, August 7 by Zacks. On Monday, March 19 the stock rating was maintained by SunTrust with “Hold”.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts